JOPIC
Journal of Pulmonology and Intensive Care

The JoPIC is an independent-unbiased, peer-reviewed, and open-access journal of current national and international issues and reviews for original clinical and experimental research, interesting case reports, surgical techniques, differential diagnoses, editorial opinions, letters to the editor, and educational papers in pulmonology, thoracic surgery, occupational diseases, allergology, and intensive care medicine. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

eISSN: 2980-0803
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Evaluation of human neutrophil gelatinase-associated lipocalin level in asthma-COPD overlap syndrome of elderly patients
Abstract
Aims: Human neutrophil gelatinase-associated lipocalin (NGAL) is a protein considered as a noninvasive prognostic biomarker in Asthma-COPD overlap syndrome (ACO). In this study we aimed to show the usability of NGAL as a biomarker in ACO characterized with airway inflammation in over 65 years old.
Methods: Three patient groups (Group I: COPD, n: 50, Group II: Asthma, n:50, Group III: ACO, n:50) and a healhty non smoker group (Group IV, n:50) are taken into study. The serum NGAL levels of groups are compared. In Group I, II, III the level of serum NGAL is compared with the age, duration of smoking (pocket/year), number of attack per year, respiratory function values, serum C reaktive protein (CRP, mg/dL), serum IgE (IU/mL) and blood neutrophil-to-lymphocyte rate and atopy.
Results: In patients having ACO when the maximum level of serum exist, it is observed that serum NGAL level is increased as the number of attacks is increased (p<0.002). On the other hand in the patients having ACO there was also positive correlation between NLR and serum NGAL level (p<0.05).
Conclusion: The increase in serum NGAL levels in chronic inflammatory lung diseases suggests that serum NGAL levels can be used as a biomarker to assess inflammation severity

Keywords : Elderly, human neutrophil gelatinase-associated lipocalin, asthma-COPD overlap syndrome

Download Article


1. Global Initiative for Asthma. 2022 GINA Main Report: Global strategyfor asthma management and prevention. Available online: www.ginasthma.org (updated 2020).
2. Barnes PJ. Immunology of asthma and chronic obstructive pulmonarydisease. Nat Rev Immunol. 2008;8(3):183-192. doi:10.1038/nri2254
3. Brusselle GG, Maes T, Bracke KR. Eosinophils in the spotlight:Eosinophilic airway inflammation in nonallergic asthma. Nat Med.2013;19(8):977-979. doi:10.1038/nm.3300
4. Al-Muhsen S, Johnson JR, Hamid Q. Remodeling in asthma. J AllergyClin Immunol. 2011;128(3):451-464. doi:10.1016/j.jaci.2011.04.047
5. Borger P, Tamm M, Black JL, Roth M. Asthma: is it due to an abnormalairway smooth muscle cell?. Am J Respir Crit Care Med. 2006;174(4):367-372. doi:10.1164/rccm.200501-082PP
6. Barnes PJ. Pathophysiology of asthma. Br J Clin Pharmacol.1996;42(1):3-10. doi:10.1046/j.1365-2125.1996.03721.x
7. Global Initiative for Chronic Obstructive Lung Disease (GOLD).2020GlobalStrategy for Prevention, Diagnosis and Management of COPD.Available from:http://goldcopd.org.
8. Higham A, Quinn AM, Can&ccedil;ado JED, Singh D. The pathology of smallairways disease in COPD: historical aspects and future directions.Respir Res. 2019;20(1):49. doi:10.1186/s12931-019-1017-y
9. Sin DD, Miravitlles M, Mannino DM, et al. What is asthma-COPD overlap syndrome? Towards a consensus definitionfrom a round table discussion. Eur Respir J. 2016;48(3):664-673.doi:10.1183/13993003.00436-2016
10. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD:what are its features and how important is it?. Thorax. 2009;64(8):728-735. doi:10.1136/thx.2008.108027
11. Diagnosis of Disease of Chronic Airflow Limitation: Asthma COPDand Asthma-COPD Overlap Syndrome (ACOS) 2014. Availablefrom:http://www.ginasthma.org/orhttp://goldcopd.org
12. Rothe T, Spagnolo P, Bridevaux PO, et al. Diagnosis and managementof asthma - the Swiss guidelines. Respiration. 2018;95(5):364-380.doi:10.1159/000486797
13. Kauppi P, Kupiainen H, Lindqvist A, et al. Overlap syndrome of asthmaand COPD predicts low quality of life. J Asthma. 2011;48(3):279-285. doi:10.3109/02770903.2011.555576
14. Miravitlles M, Soriano JB, Ancochea J, et al. Characterisation ofthe overlap COPD-asthma phenotype. Focus on physical activityand health status. Respir Med. 2013;107(7):1053-1060. doi:10.1016/j.rmed.2013.03.007
15. Weatherall M, Travers J, Shirtcliffe PM, et al. Distinct clinicalphenotypes of airways disease defined by cluster analysis. Eur Respir J.2009;34(4):812-818. doi:10.1183/09031936.00174408
16. Hardin M, Silverman EK, Barr RG, et al. The clinical features ofthe overlap between COPD and asthma. Respir Res. 2011;12(1):127.doi:10.1186/1465-9921-12-127
17. Kjeldsen L, Bainton DF, Sengel&oslash;v H, Borregaard N. Identification ofneutrophil gelatinase-associated lipocalin as a novel matrix protein ofspecific granules in human neutrophils. Blood. 1994;83(3):799-807.
18. Chakraborty S, Kaur S, Guha S, Batra SK. The multifaceted roles ofneutrophil gelatinase associated lipocalin (NGAL) in inflammationand cancer. Biochim Biophys Acta. 2012;1826(1):129-169. doi:10.1016/j.bbcan.2012.03.008
19. Sivalingam Z, Larsen SB, Grove EL, Hvas AM, Kristensen SD,Magnusson NE. Neutrophil gelatinase-associated lipocalin as a riskmarker in cardiovascular disease. Clin Chem Lab Med. 2017;56(1):5-18.doi:10.1515/cclm-2017-012020. Global Initiative for Asthma, Global Initiative for Chronic Obstructive
20. Lung Disease, Diagnosis of Disease of Chronic Airflow Limitation.Asthma, COPD, and asthma-COPD overlap syndrome (ACOS); 2015.Available from: http://www.ginasthma.org/. Accessed November4,2020.
21. Ghosh N, Choudhury P, Kaushik SR, et al. Metabolomic fingerprintingand systemic inflammatory profiling of asthma COPD overlap (ACO).Respir Res. 2020;21(1):126. doi:10.1186/s12931-020-01390-4
22. Cowland JB, S&oslash;rensen OE, Sehested M, Borregaard N. Neutrophilgelatinase-associated lipocalin is up-regulated in human epithelialcells by IL-1 beta, but not by TNF-alpha. J Immunol. 2003;171(12):6630-6639. doi:10.4049/jimmunol.171.12.6630
23. Wang Y, Jia M, Yan X, et al. Increased neutrophil gelatinase-associatedlipocalin (NGAL) promotes airway remodelling in chronic obstructivepulmonary disease. Clin Sci (Lond). 2017;131(11):1147-1159. doi:10.1042/CS20170096
24. Gao J, Iwamoto H, Koskela J, et al. Characterization of sputumbiomarkers for asthma-COPD overlap syndrome. Int J Chron ObstructPulmon Dis. 2016;11:2457-2465. doi:10.2147/COPD.S113484
25. Keatings VM, Barnes PJ. Granulocyte activation markers in inducedsputum: comparison between chronic obstructive pulmonarydisease, asthma, and normal subjects. Am J Respir Crit Care Med.1997;155(2):449-453. doi:10.1164/ajrccm.155.2.9032177
26. Bchir S, Nasr HB, Bouchet S, et al. Concomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum ofsmokers with chronic obstructive pulmonary disease. J Cell Mol Med.2017;21(7):1280-1291. doi:10.1111/jcmm.13057
27. Treeprasertsuk S, Wongkarnjana A, Jaruvongvanich V, et al. Urineneutrophil gelatinase-associated lipocalin: a diagnostic and prognosticmarker for acute kidney injury (AKI) in hospitalized cirrhoticpatients with AKI-prone conditions. BMC Gastroenterol. 2015;15:140.doi:10.1186/s12876-015-0372-5
28. Lorenzo-G&oacute;mez MF, Flores-Fraile MC, M&aacute;rquez-S&aacute;nchez M, et al.Increased urinary markers of kidney damage in the institutionalizedfrail elderly due to recurrent urinary tract infections. Ther Adv Urol.2020;12:1756287220974133. doi:10.1177/1756287220974133
29. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associatedlipocalin (NGAL) as a biomarker for acute renal injury after cardiacsurgery. Lancet. 2005;365(9466):1231-1238. doi:10.1016/S0140-6736(05)74811-X
30. Cao J, Lu X, Gao F, Zhang X, Xia X, Sun H. Assessment of neutrophilgelatinase-associated lipocalin as an early biomarker for caninerenal ischemia-reperfusion injury. Ann Transl Med. 2020;8(22):1491.doi:10.21037/atm-20-6314
31. Navratilova Z, Kolek V, Petrek M. Matrix metalloproteinases and theirinhibitors in chronic obstructive pulmonary disease. Arch ImmunolTher Exp (Warsz). 2016;64(3):177-193. doi:10.1007/s00005-015-0375-5
32. Navratilova Z, Kolek V, Petrek M. Matrix metalloproteinases and theirinhibitors in chronic obstructive pulmonary disease. Arch ImmunolTher Exp (Warsz). 2016;64(3):177-193. doi:10.1007/s00005-015-0375-5
33. Williams KA, Labidi-Galy SI, Terry KL, et al. Prognostic significanceand predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer.Gynecol Oncol. 2014;132(3):542-550. doi:10.1016/j.ygyno.2014.01.026
34. Kacan T, Babacan NA, Seker M, et al. Could the neutrophil tolymphocyte ratio be a poor prognostic factor for non small cell lungcancers?. Asian Pac J Cancer Prev. 2014;15(5):2089-2094. doi:10.7314/apjcp.2014.15.5.2089
35. Paliogiannis P, Scognamillo F, Bellomo M, et al. Neutrophil tolymphocyte ratio as a predictor of thyroid papillary carcinoma. ActMed Mediterr. 2015; 31: 371-5.
36. Stotz M, Gerger A, Eisner F, et al. Increased neutrophil-lymphocyteratio is a poor prognostic factor in patients with primary operableand inoperable pancreatic cancer. Br J Cancer. 2013;109(2):416-421.doi:10.1038/bjc.2013.332
37. Lee SJ, Lee HR, Lee TW, et al. Usefulness of neutrophil to lymphocyteratio in patients with chronic obstructive pulmonary disease: aprospective observational study. Korean J Intern Med. 2016;31(5):891-898. doi:10.3904/kjim.2015.084
38. Lee H, Um SJ, Kim YS, et al. Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients withchronic obstructive pulmonary disease. PLoS One. 2016;11(6):e0156511.doi:10.1371/journal.pone.0156511
39. Paliogiannis P, Fois AG, Sotgia S, et al. Neutrophil to lymphocyte ratioand clinical outcomes in COPD: recent evidence and future perspectives.Eur Respir Rev. 2018;27(147):170113. doi:10.1183/16000617.0113-2017
40. Pilaczynska-Cemel M, Golda R, Dabrowska A, Przybylski G. Analysisof the level of selected parameters of inflammation, circulating immunecomplexes, and related indicators (neutrophil/lymphocyte, platelet/lymphocyte, CRP/CIC) in patients with obstructive diseases. Cent Eur JImmunol. 2019;44(3):292-298. doi:10.5114/ceji.2019.87498
41. Li M, Yang T, He R, et al. The value of inflammatory biomarkers indifferentiating asthma-COPD overlap from COPD. Int J Chron ObstructPulmon Dis. 2020;15:3025-3037. doi:10.2147/COPD.S273422
42. Sakurai K, Chubachi S, Irie H, et al. Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients. BMC Pulm Med.2018;18(1):65. doi:10.1186/s12890-018-0639-z
43. Len&aacute;rtov&aacute; P, Kopcekov&aacute; J, Gazarov&aacute; M, Mr&aacute;zov&aacute; J, Wyka J. Biochemicalparameters as monitoring markers of the inflammatory reaction bypatients with chronic obstructive pulmonary disease (COPD). RoczPanstw Zakl Hig. 2017;68(2):185-190.
44. Pilaczynska-Cemel M, Golda R, Dabrowska A, Przybylski G. Analysisof the level of selected parameters of inflammation, circulating immunecomplexes, and related indicators (neutrophil/lymphocyte, platelet/lymphocyte, CRP/CIC) in patients with obstructive diseases. Cent Eur JImmunol. 2019;44(3):292-298. doi:10.5114/ceji.2019.87498
45. Fu JJ, McDonald VM, Gibson PG, Simpson JL. Systemic inflammationin older adults with asthma-COPD overlap syndrome. Allergy AsthmaImmunol Res. 2014;6(4):316-324. doi:10.4168/aair.2014.6.4.316
46. Menezes AMB, Montes de Oca M, P&eacute;rez-Padilla R, et al. Increasedrisk of exacerbation and hospitalization in subjects with an overlapphenotype: COPD-asthma. Chest. 2014;145(2):297-304. doi:10.1378/chest.13-0622
47. Zeki AA, Schivo M, Chan A, Albertson TE, Louie S. The asthma-COPDoverlap syndrome: a common clinical problem in the elderly. J Allergy(Cairo). 2011;2011:861926. doi:10.1155/2011/861926
Article available in :
Volume 1, Issue 2, 2023
Page : 32-37
https://doi.org/10.51271/JOPIC-0008
Article Information
Received : 10 Nis 2023
Accepted : 04 May 2023
Published : 22 May 2023
Corresponding Author :

Serap Duru: Ankara Etlik City Hospital

[email protected]
Citation : Duru S, Uçar F. Evaluation of human neutrophil gelatinase-associated lipocalin level in asthma-COPD overlap syndrome of elderly patients. J Pulmonol Intens Care. 2023;1(2):32-37.

Read: 296
Cited: 0
Download : 158
_Footer